🟢 Merck KGaA is trading 4.15% up with no identified company-specific catalyst

Merck KGaA is trading 4.15% higher at €141.70; available reporting does not identify a fresh company-specific announcement explaining the move.

• The rise is notable after the October 5 close of €136.05.
• The Bio-Techne acquisition was announced earlier, and shareholder approval was reported on September 23. The evidence does not establish it as the cause of the October 6 gain.